Revolution Medicines Inc to Host Investor Call Transcript
Thank you, and welcome, everyone, to the webcast. Joining me on today's call are Dr. Mark Goldsmith, Revolution Medicine's Chairman and Chief Executive Officer; and Dr. Wei Lin, our Chief Medical Officer; Dr. Steve Kelsey, our President of R&D; Dr. Alan Sandler, our Chief Development Officer; Anthony Mancini, our Chief Global Commercialization Officer; and Jack Anders, our Chief Financial Officer, who will join us for the Q&A portion of today's call.
As we begin our presentation, I would ask that you review our legal disclaimer on slide 2.
And with that, I'll turn the call over to Dr. Mark Goldsmith, our Chairman and Chief Executive Officer. Mark?
Thank you, Ryan, and thank you, everyone, for joining us.
Today marks an important landmark for patients living with metastatic pancreatic cancer and a major milestone for Revolution Medicines. This
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
